Référentiel des médicaments
Delgocitinib
Delgocitinib is a medicine in the class miscellaneous. It is used for eczema.
- Classe médicamenteuse: Miscellaneous
- Indications: eczema
Dernière mise à jour Sources: US FDA label
Réservé aux professionnels de santé — à titre de référence uniquement. Cette page est un bref résumé, pas un avis médical, et ne remplace ni la notice officielle ni le jugement clinique. Vérifiez toujours avant de prescrire ou de délivrer.
Le contenu clinique de cette page n'est disponible qu'en anglais.
L'essentiel
- Classe médicamenteuse
- Miscellaneous
- Code ATC
- D11AH11
- Formes courantes
- crème
- Dosages courants
- 20 mg/g
- Noms commerciaux
- 2
- Pays et marchés
- 2
Indications
Mécanisme d'action
Janus kinase (JAK) inhibitor that inhibits the activity of JAK1, JAK2, JAK3 and TYK2, interfering with JAK-STAT cytokine signaling. The exact mechanism in chronic hand eczema is not known.
Posologie adulte habituelle (résumé de la notice)
Moderate to severe chronic hand eczema: apply a thin layer topically twice daily to affected areas of the hands and wrists only; do not use more than 30 grams per 2 weeks or 60 grams per month
Grossesse et allaitement
- Grossesse
- Unknown Cream for chronic hand eczema; little is absorbed through the skin. Human data are insufficient; oral doses over 100 times human exposure caused no developmental harm in rats and rabbits. Use only if needed.
- Allaitement
- Unknown No human milk data; present in rat milk after oral dosing. Topical use gives low exposure. US label: weigh breastfeeding against need; avoid direct infant contact with the nipple area right after applying to hands or wrists.
Effets indésirables signalés
- Application site pain
- Paresthesia
- Pruritus
- Erythema
- Bacterial skin infections including finger cellulitis and paronychia
- Leukopenia and neutropenia
Contre-indications
- None listed in the US prescribing information (section 4 Contraindications: "None"; Anzupgo, DailyMed set id a59bf36e-6f04-4b47-b385-8040c95f040c).
Précautions particulières
- May increase risk of infections, including eczema herpeticum; avoid use in patients with an active or serious infection.
- Viral reactivation (e.g., herpes zoster) reported; not recommended in active hepatitis B or C; consider hepatitis screening.
- Non-melanoma skin cancers reported; periodic skin examinations recommended; limit sun exposure.
Informez votre pharmacien ou votre médecin en cas de grossesse ou d'allaitement, de maladie rénale ou hépatique, d'allergies, ainsi que de tout autre médicament ou complément que vous prenez.
Réservé aux membres Pro+
Débloquer la page complète
Créez un compte et lancez un essai Pro+ pour ouvrir la monographie complète de Delgocitinib : posologie, grossesse et allaitement, effets indésirables, mises en garde et toutes les interactions.
- Dosing by age, kidney and liver function, and further dose lines
- Renal and hepatic dose adjustments
- Dosing in older adults
- How to give it
- Pharmacokinetics
- Patient counselling points
Essayez Pro+ gratuitement pendant 7 jours sur le web. Sans carte.
Questions fréquentes
What is Delgocitinib used for?
Delgocitinib is a medicine in the class miscellaneous. It is used for Eczema.
What side effects have been reported with Delgocitinib?
Application site pain, Paresthesia, Pruritus, Erythema, Bacterial skin infections including finger cellulitis and paronychia, Leukopenia and neutropenia.
Can Delgocitinib be taken in pregnancy or while breastfeeding?
Pregnancy: Unknown. Cream for chronic hand eczema; little is absorbed through the skin. Human data are insufficient; oral doses over 100 times human exposure caused no developmental harm in rats and rabbits. Use only if needed. Breastfeeding: Unknown. No human milk data; present in rat milk after oral dosing. Topical use gives low exposure. US label: weigh breastfeeding against need; avoid direct infant contact with the nipple area right after applying to hands or wrists.
What does Delgocitinib interact with?
MediHelp does not list a checked interaction for Delgocitinib yet. Always tell your pharmacist about every medicine you take.
Monographies complètes, posologies et vérificateur d'interactions dans l'application MediHelp
Ouvrez le référentiel complet, vérifiez les interactions entre plusieurs médicaments et utilisez les outils de posologie dans l'application MediHelp.
